1. Comparison of early postoperative outcomes between omega-like duct-to-mucosa pancreatojejunostomy and conventional duct-to-mucosa pancreatojejunostomy after pancreaticoduodenectomy. Issue 5 (May 2022) Authors: Zheng, Minghui; Liu, Anan; Li, Judong; Liang, Xing; Peng, Junfeng; Chen, Danlei; Shi, Ligang; Fu, Zhiping; Ji, Meng; Yang, Guang; Yang, Tianbo; Tang, Liang; Shao, Chenghao Journal: HPB Issue: Volume 24:Issue 5(2022) Page Start: 606 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of a Gene Risk Signature for Patients of Pancreatic Cancer. (7th January 2022) Authors: Liu, Tao; Chen, Long; Gao, Guili; Liang, Xing; Peng, Junfeng; Zheng, Minghui; Li, Judong; Ye, Yongqiang; Shao, Chenghao Other Names: Rajakani Kalidoss Academic Editor. Journal: Journal of healthcare engineering Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Guidelines for the diagnosis and treatment of acute pancreatitis in China (2021). Issue 2 (7th June 2021) Authors: Li, Fei; Cai, Shouwang; Cao, Feng; Chen, Rufu; Fu, Deliang; Ge, Chunlin; Hao, Chunyi; Hao, Jihui; Huang, Heguang; Jian, Zhixiang; Jin, Gang; Li, Ang; Li, Haimin; Li, Shengping; Li, Weiqin; Li, Yixiong; Liang, Tingbo; Liu, Xubao; Lou, Wenhui; Miao, Yi Other Names: collaborator. Journal: Journal of pancreatology Issue: Volume 4:Issue 2(2021) Page Start: 67 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Guidelines for the diagnosis and treatment of pancreatic cancer in China (2021). Issue 2 (7th June 2021) Authors: Yang, Yinmo; Bai, Xueli; Bian, Dapeng; Cai, Shouwang; Chen, Rufu; Cao, Feng; Dai, Menghua; Fang, Chihua; Fu, Deliang; Ge, Chunlin; Guo, Xiaochao; Hao, Chunyi; Hao, Jihui; Huang, Heguang; Jian, Zhixiang; Jin, Gang; Li, Fei; Li, Haimin; Li, Shengping; Li, Weiqin Other Names: collaborator. Journal: Journal of pancreatology Issue: Volume 4:Issue 2(2021) Page Start: 49 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. HH1-1, a novel Galectin-3 inhibitor, exerts anti-pancreatic cancer activity by blocking Galectin-3/EGFR/AKT/FOXO3 signaling pathway. (15th January 2019) Authors: Yao, Yanli; Zhou, Lishuang; Liao, Wenfeng; Chen, Huanjun; Du, Zhenyun; Shao, Chenghao; Wang, Peipei; Ding, Kan Journal: Carbohydrate polymers Issue: Volume 204(2019) Page Start: 111 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. LncRNA H19 binds VGF and promotes pNEN progression via PI3K/AKT/CREB signaling. Issue 4 (April 2021) Authors: Ji, Meng; Yao, Yanli; Liu, Anan; Shi, Ligang; Chen, Danlei; Tang, Liang; Yang, Guang; Liang, Xing; Peng, Junfeng; Shao, Chenghao Journal: Endocrine-related cancer Issue: Volume 28:Issue 4(2021) Page Start: X1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LncRNA H19 binds VGF and promotes pNEN progression via PI3K/AKT/CREB signaling. Issue 7 (July 2019) Authors: Ji, Meng; Yao, Yanli; Liu, Anan; Shi, Ligang; Chen, Danlei; Tang, Liang; Yang, Guang; Liang, Xing; Peng, Junfeng; Shao, Chenghao Journal: Endocrine-related cancer Issue: Volume 26:Issue 7(2019) Page Start: 643 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Long noncoding RNA‐mRNA expression profiles and validation in pancreatic neuroendocrine neoplasms. (25th January 2020) Authors: Ji, Meng; Tang, Liang; Ding, Rumei; Shi, Ligang; Liu, Anan; Chen, Danlei; Shao, Chenghao Journal: Clinical endocrinology Issue: Volume 92:Number 4(2020) Page Start: 312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MiR‐545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG‐I. Issue 23 (12th October 2014) Authors: Song, Bin; Ji, Weiping; Guo, Shiwei; Liu, Anan; Jing, Wei; Shao, Chenghao; Li, Gang; Jin, Gang Journal: FEBS letters Issue: Volume 588:Issue 23(2014) Page Start: 4375 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression. (2nd May 2019) Authors: Li, Zhang; Shao, Chenghao; Liu, Xiaoxiao; Lu, Xiaojing; Jia, Xiaona; Zheng, Xufen; Wang, Simin; Zhu, Li; Li, Ke; Pang, Yuzhi; Xie, Feifei; Lu, Yuan; Wang, Yuexiang Journal: Carcinogenesis Issue: Volume 41:Number 1(2020) Page Start: 44 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗